Table 2.
Canonical Pathways Observed in Cluster 2, Characterizing Proteins with Higher Expression at Four Observed Developmental Days (47, 108, 122, and 137) in Comparison to Adult Tissue
| Canonical pathways | P | Proteins |
|---|---|---|
| Mismatch repair in eukaryotes | 2.09E-05 | PCNA, MSH6, FEN1 |
| BER pathway | 6.92E-04 | PCNA, FEN1 |
| LPS/IL-1 mediated inhibition of RXR function | 4.68E-03 | ALDH1A2, CPT2, ALDH18A1, FABP5 |
| Glycine biosynthesis I | 1.82E-02 | SHMT2 |
| Clathrin-mediated endocytosis signaling | 1.95E-02 | CSNK2A2, CLTA, USP9X |
| AMPK signaling | 2.14E-02 | CPT2, SMARCC1, PPM1G |
| RAR activation | 2.19E-02 | CSNK2A2, ALDH1A2, SMARCC1 |
| Role of BRCA1 in DNA damage response | 2.34E-02 | MSH6, SMARCC1 |
| Thioredoxin pathway | 2.40E-02 | NXN |
| Cleavage and polyadenylation of pre-mRNA | 3.55E-02 | CSTF3 |
| Acyl-CoA hydrolysis | 4.20E-02 | ACOT7 |
| Proline biosynthesis I | 4.20E-02 | ALDH18A1 |
| dTMP De Novo biosynthesis | 4.20E-02 | SHMT2 |